A Single-Dose Gene Therapy May Offer a Future Therapeutic Option for Wet AMD
- Posted on: May 2 2024
- Leave a response
A phase 1 study found that a novel intravitreal gene therapy that induces aflibercept production may be able to minimize reliance on anti-VEGF injections in patients with neovascular AMD.
Source: AAO
Posted in: Uncategorized
